Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite

Pemetrexed plus either cisplatin or carboplatin are active and well tolerated first-line treatments of extensive-stage small-cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

By Yana Takashi   Negoro Shunichi   Takada Minoru   Yokota Soichiro   Takada Yoshiki   Sugiura Takahiko   Yamamoto Hidehiko   Sawa Toshiyuki   Kawahara Masaaki   Katakami Nobuyuki   Ariyoshi Yutaka   Fukuoka Masahiro  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 253-258

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

By Schelman William   Mohammed Tabraiz   Traynor Anne   Kolesar Jill   Marnocha Rebecca   Eickhoff Jens   Keppen Michael   Alberti Dona   Wilding George   Takebe Naoko   Liu Glenn  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 295-302

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with irinotecan plus cisplatin has a similar survival benefit to etoposide plus cisplatin in patients with extensive-stage small cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite